Bolt Biotherapeutics (BOLT) Stock: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$3.95
0.22 (5.90%)
â˛
5d:
+1.41%
30d:
+14.49%
90d:
-17.19%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BOLT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BOLT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $3.95, which is considered slightly high relative to its 30-day fair value range of $3.43 to $4.02.
Technical Outlook: Technically, BOLT is in a strong downtrend. Immediate support is located at $3.25, while resistance sits at $4.27. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: BOLT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $29.00 (+634.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLT is in a strong downtrend. Immediate support is located at $3.25, while resistance sits at $4.27. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: BOLT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $29.00 (+634.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.43 -
$4.02
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.9%)
- BULLISH: Trading 634.2% below Wall St target ($29.00)
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.43 -
$4.02
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.25
Resistance Level
$4.27
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.20
Wall Street Target
$29.00
(+634.2%)
Revenue Growth (YoY)
-99.7%
Share & Embed Analysis
Last updated: September 13, 2026 12:54 AM ET
Data refreshes hourly during market hours. Next update: 1:54 AM
Data refreshes hourly during market hours. Next update: 1:54 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 47 HOLD |
